Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kit; and Changdian II, a house dust mite skin prick diagnosis kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 and is headquartered in Huzhou, China.
Metrics to compare | 300357 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300357PeersSector | |
---|---|---|---|---|
P/E Ratio | 41.7x | 32.3x | −0.5x | |
PEG Ratio | −66.50 | −1.04 | 0.00 | |
Price/Book | 5.4x | 3.0x | 2.6x | |
Price / LTM Sales | 14.0x | 4.4x | 3.2x | |
Upside (Analyst Target) | −6.1% | 12.2% | 41.9% | |
Fair Value Upside | Unlock | 4.4% | 4.3% | Unlock |